Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
life sciences
national blog main
national top stories
novartis
4
×
boston blog main
boston top stories
clinical trials
fda
new york top stories
san francisco top stories
amgen
eli lilly
europe top stories
genentech
indiana blog main
indiana top stories
national
new york blog main
roche
san francisco blog main
alder biopharmaceuticals
alirocumab
alnylam pharmaceuticals
avapritinib
billy dunn
biogen
blueprint medicines
boston
boulder/denver blog main
boulder/denver top stories
calcitonin gene-related peptide
cancer
cancer drugs
capmatinib
chronic migraine
david rind
deals
detroit blog main
detroit top stories
What
drug
4
×
fda
4
×
medicines
new
approval
therapy
acquire
address
agreed
amgen
approved
approves
atrophy
billion
blueprint
brings
cancer
candidates
carries
cash
certain
cholesterol
class
company
compound
daily
deal
designed
developed
evrysdi
friday
genetic
gets
green
head
home
intended
latest
lights
liquid
Language
unset
Current search:
drug
×
biotech
×
novartis
×
fda
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines